Showing 8,121 - 8,140 results of 32,731 for search '(( 50 ((we decrease) OR (((mean decrease) OR (a decrease)))) ) OR ( e point decrease ))', query time: 0.69s Refine Results
  1. 8121

    Incidence of bone and osteoid tissue formation in different animals (A–D) and percentage of bone area in pores of dogs (E) at 6, 12 and 24 after implantation. by Liao Wang (630699)

    Published 2014
    “…In dogs, osteoid formation was observed in all ceramics at all time points, except in HA1200 at 6 weeks. Like in rabbits, a decreasing osteoid incidence was observed from BCP11 to BCP1200 to HA1200 (C). …”
  2. 8122

    Rho inactivation negatively affects biofilm formation in <i>B</i>. <i>subtilis</i>. by Vladimir Bidnenko (4258573)

    Published 2017
    “…(B and C) Rho inactivation decreases expression of biofilm-specific genes. Promoters of the operons <i>epsA-O</i> (B) and <i>tapA-sipW-tasA</i> (C) encoding exopolysaccharides and amyloid-like protein fibers, respectively, were fused to the butterfly luciferase gene <i>luc</i> and tested for transcription activity in <i>B</i>. …”
  3. 8123

    Climate complexity in the migratory cycle of <i>Ammodramus bairdii</i> by Alexander Peña-Peniche (5687786)

    Published 2018
    “…A continuous and alarming decrease of its populations has been observed over the last 50 years, and studying its seasonal distribution and associated climatic niches could help improve strategies for its conservation. …”
  4. 8124
  5. 8125
  6. 8126
  7. 8127
  8. 8128
  9. 8129
  10. 8130
  11. 8131
  12. 8132
  13. 8133
  14. 8134
  15. 8135
  16. 8136
  17. 8137
  18. 8138

    PCAIs inhibit NCI-H23 cell line viability. by Matthew D. Gregory (19929096)

    Published 2024
    “…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
  19. 8139

    PCAIs disrupt actin filaments in NCI-H23 cells. by Matthew D. Gregory (19929096)

    Published 2024
    “…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”
  20. 8140

    PCAIs suppress 3D NCI-H23 cell invasion. by Matthew D. Gregory (19929096)

    Published 2024
    “…Polyisoprenylated Cysteinyl amide Inhibitors (PCAIs) constitute a group of potential cancer therapy agents that we designed to specifically disrupt and suppress hyperactive G-protein signaling, such as that caused by mutated RAS proteins. …”